3-50341912-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015896.4(ZMYND10):​c.1019G>A​(p.Arg340Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00267 in 1,614,188 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R340W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0027 ( 20 hom. )

Consequence

ZMYND10
NM_015896.4 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.60

Publications

8 publications found
Variant links:
Genes affected
ZMYND10 (HGNC:19412): (zinc finger MYND-type containing 10) This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
ZMYND10-AS1 (HGNC:40890): (ZMYND10 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0070642233).
BP6
Variant 3-50341912-C-T is Benign according to our data. Variant chr3-50341912-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00254 (387/152384) while in subpopulation NFE AF = 0.00369 (251/68038). AF 95% confidence interval is 0.00331. There are 2 homozygotes in GnomAd4. There are 175 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZMYND10NM_015896.4 linkc.1019G>A p.Arg340Gln missense_variant Exon 10 of 12 ENST00000231749.8 NP_056980.2
ZMYND10NM_001308379.2 linkc.1004G>A p.Arg335Gln missense_variant Exon 9 of 11 NP_001295308.1
ZMYND10XM_005265216.4 linkc.782G>A p.Arg261Gln missense_variant Exon 9 of 11 XP_005265273.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZMYND10ENST00000231749.8 linkc.1019G>A p.Arg340Gln missense_variant Exon 10 of 12 1 NM_015896.4 ENSP00000231749.3

Frequencies

GnomAD3 genomes
AF:
0.00254
AC:
387
AN:
152266
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00369
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00281
AC:
706
AN:
251174
AF XY:
0.00281
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00292
Gnomad ASJ exome
AF:
0.00855
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00157
Gnomad NFE exome
AF:
0.00360
Gnomad OTH exome
AF:
0.00523
GnomAD4 exome
AF:
0.00268
AC:
3918
AN:
1461804
Hom.:
20
Cov.:
32
AF XY:
0.00273
AC XY:
1984
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33476
American (AMR)
AF:
0.00347
AC:
155
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00903
AC:
236
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00147
AC:
127
AN:
86258
European-Finnish (FIN)
AF:
0.00157
AC:
84
AN:
53384
Middle Eastern (MID)
AF:
0.00815
AC:
47
AN:
5766
European-Non Finnish (NFE)
AF:
0.00274
AC:
3051
AN:
1111982
Other (OTH)
AF:
0.00341
AC:
206
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
276
552
827
1103
1379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00254
AC:
387
AN:
152384
Hom.:
2
Cov.:
33
AF XY:
0.00235
AC XY:
175
AN XY:
74526
show subpopulations
African (AFR)
AF:
0.000721
AC:
30
AN:
41590
American (AMR)
AF:
0.00314
AC:
48
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00865
AC:
30
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4834
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00369
AC:
251
AN:
68038
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00283
Hom.:
2
Bravo
AF:
0.00296
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00453
AC:
39
ExAC
AF:
0.00275
AC:
334
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00431
EpiControl
AF:
0.00528

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ZMYND10: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia 22 Benign:1
Dec 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.10
T;.
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.79
T;T
M_CAP
Benign
0.0055
T
MetaRNN
Benign
0.0071
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
1.6
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.79
N;N
REVEL
Benign
0.051
Sift
Benign
0.33
T;T
Sift4G
Benign
0.33
T;T
Polyphen
0.010
B;B
Vest4
0.30
MVP
0.072
MPC
0.19
ClinPred
0.0087
T
GERP RS
4.1
Varity_R
0.075
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148328402; hg19: chr3-50379343; COSMIC: COSV51600830; COSMIC: COSV51600830; API